Ledger.Open graph →
SEC Form D · filed May 9, 2018

CAMBRIDGE EPIGENETIX Ltd

Offering
$12.3M
Sold
$12.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Alice Newcombe-Ellis · Cambridge, United KingdomDirectorSomasundaram Subramaniam · Nijmegen, P7DirectorMartin Murphy · San Francisco, CADirectorJason Mellad · Cambridge, United KingdomExec · DirectorBobby Yerramilli-Rao · San Francisco, CADirectorTimothy Rink · Cambridge, United KingdomDirectorThomas Hulme · Cambridge, United KingdomDirectorShankar Balasubramanian · Cambridge, United KingdomDirectorMartin Murphy · IRVINE, CADirectorJason Mellad · Cambridge, United KingdomExec · DirectorBobby Yerramilli-Rao · Cambridge, United KingdomDirectorAlice Newcombe-Ellis · Cambridge, United KingdomDirectorSomasundaram Subramaniam · Redwood City, CADirectorTimothy Rink · Cambridge, United KingdomDirectorThomas Hulme · Cambridge, United KingdomDirectorShankar Balasubramanian · Cambridge, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗